SHINE Technologies (Series B)
Funding Details
Awarder
Inbox
Date Award
March 2, 2026
Vertical
Nuclear Technology
Funding Amount
$250,000,000
Company Info
Founders
Greg Piefer
Market
Medical Isotope Production
Location
Janesville, Wisconsin, United States
Coinvestors
Deerfield Management Company, L.P., Fidelity Management & Research Company, NantWorks, Oaktree Capital Management, Pelican Energy Partners, Sumitomo Corporation
Company Description

Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, cost-efficiency and environmental responsibility. SHINE has successfully commercialized fusion across multiple applications, including neutron testing markets such as neutron radiography, radiation-effects testing and fusion material research. It has commercialized and is scaling its proprietary medical isotope production and processes, supplying high-quality radioisotopes essential for procedures including diagnosing heart disease and cancer as well as cancer therapy.

Links